All In Biotech

Drug Trial Radar · NCT04987203

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

TiNivo-2: A Phase 3, Randomized, Controlled, Multicenter, Open-label Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma Who Have Progressed Following One or Two Lines of Therapy Where One Line Has an Immune Checkpoint Inhibitor

Last checked: Nov 19, 2026Latest source record: May 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 343 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

343

Actual

Start

Sep 9, 2021

Primary completion

Jan 20, 2026

Study completion Jan 20, 2026

Sponsor

Lead sponsor
AVEO Pharmaceuticals, Inc.Industry
Sponsor type
Industry
Collaborators
Parexel; Bristol-Myers Squibb
First posted
Aug 3, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 130 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will be comparing tivozanib in combination with nivolumab to tivozanib alone in subjects with advanced Renal Cell Carcinoma (RCC) who have had 1 or 2 prior lines of therapy, one of which was an Immune Checkpoint Inhibitor (ICI).

Conditions

  • Renal Cell Carcinoma

Interventions

  • TivozanibDrug

    Tivozanib will be administered orally.

  • NivolumabDrug

    Nivolumab will be administered via intravenous infusion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression free survivalTime frame: Until progressive disease [PD] (Approximately 30 months)

Locations

139 sites in 16 countries. Site status is shown where the registry gives one.

  • City of Hope Comprehensive Cancer Center

    Duarte, California

  • Chao Family Comprehensive Cancer Center, UC Irvine

    Irvine, California

  • University of California San Diego

    La Jolla, California

  • Leland Stanford Junior University

    Redwood City, California

  • Kaiser Permanente Riverside Medical Center

    Riverside, California

  • US Oncology - Rocky Mountain Cancer Centers - Midtown

    Denver, Colorado

  • Florida Cancer Specialists & Res Inst

    Fort Myers, Florida

  • Florida Cancer Specialists & Research Institute (FCS) - Tampa Cancer Center Location

    St. Petersburg, Florida

  • The University of Kansas Cancer Center

    Westwood, Kansas

  • University of Kentucky UK Markey Cancer Center

    Lexington, Kentucky

  • Tulane Cancer Center Clinic - Oncology

    New Orleans, Louisiana

  • University of Maryland Medical Center-Greenebaum Cancer Ctr

    Baltimore, Maryland

  • John Hopkins Medicine - Hematology/oncology

    Baltimore, Maryland

  • Maryland Oncology Hematology

    Clinton, Maryland

  • Dana-Farber Cancer Institute - Medicine

    Boston, Massachusetts

  • Henry Ford Hospital

    Detroit, Michigan

  • St. Vincent Frontier Cancer Center

    Billings, Montana

  • Oncology Hematology West PC dba Nebraska Cancer Specialists

    Omaha, Nebraska

  • Memorial Sloan Kettering Cancer Center - Monmouth - Oncology

    Middletown, New Jersey

  • University of New Mexico - Comprehensive Cancer Center

    Albuquerque, New Mexico

  • Roswell - Roswell Park Cancer Institute - Medical Oncology

    Buffalo, New York

  • Memorial Sloan Kettering Cancer Center - Westchester

    East White Plains, New York

  • Memorial Sloan Kettering Cancer Center (MSKCC) - Memorial Hospital

    New York, New York

  • Memorial Sloan Kettering Cancer Center - Nassau

    Uniondale, New York

  • Cleveland Clinic

    Cleveland, Ohio

  • Lehigh Valley Physician Group

    Allentown, Pennsylvania

  • Allegheny General Hospital (AGH)

    Pittsburgh, Pennsylvania

  • UH Cleveland Medical Center

    Columbia, South Carolina

  • Chattanooga Oncology and Hematology Associates

    Chattanooga, Tennessee

  • Tennessee Oncology, PLLC

    Nashville, Tennessee

  • Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee

  • Texas Oncology - Central Austin Cancer Center

    Austin, Texas

  • Texas Oncology - Baylor Charles A. Sammons Cancer Center

    Dallas, Texas

  • US Oncology Texas Oncology (CCC of South Texas) - San Antonio Medical Center

    San Antonio, Texas

  • University Of Washington - Medical Center

    Seattle, Washington

  • Northwest Medical Specialties PLLC

    Tacoma, Washington

  • Centro Oncológico Korben

    Buenos Aires, Ciudad Autónoma de Buenos Aire, Argentina

  • Clínica Viedma

    Viedma, Río Negro Province, Argentina

  • Centro Oncologico de Rosario

    Rosario, Santa Fe Province, Argentina

  • Centro para la Atención Integral del paciente Oncológico

    San Miguel de Tucumán, Tucumán Province, Argentina

Showing 40 of 139 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.